Adial Pharmaceuticals Statistics
NASDAQ: ADILHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.99+0.01 (+0.25%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Adial Pharmaceuticals by the numbers
Adial Pharmaceuticals has a market capitalization of $10.5 million based on 2.63M shares outstanding. With trailing EPS of $-20.65, Adial Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.4% below its 50-day average and 16.8% above its 200-day average.
Average daily trading volume is 57.60K shares, or about $229,840 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ADIL valuation vs. peer median
| Metric | ADIL | Peer median | Difference |
|---|---|---|---|
| Market cap | $10.48M | $10.69M | -2% |
| Avg. volume | 57.60K | 347.54K | -83% |
Peer median across 8 companies: APUS, TOVX, CALC, CMMB, VTGN, BLRX, JAGX, GTBP.
Valuation
- Market cap
- $10.48M
- EPS (TTM)
- $-20.65
- Shares outstanding
- 2.63M
Price and trading
- Previous close
- 3.98
- Open
- 3.96
- Day range
- 3.92 – 4.08
- 52-week range
- 1.31 – 10.75
- 52-week change
- -59.08%
- Beta
- —
- Volume
- 4.41K
- Average volume
- 57.60K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 10.48M
- Forward Pe
- -0.54
- Eps
- -20.65
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.75
- Week52 Low
- 1.31
- Avg Volume
- 57,604.00
- Shares Outstanding
- 2.63M
- Ma50
- 4.83
- Ma200
- 3.41
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -62.88%
- Pct From52w Low
- 204.58%